| Literature DB >> 24678003 |
Stefan Johansson1, Siren Berland, Gyri Aasland Gradek, Ernie Bongers, Nicole de Leeuw, Rolph Pfundt, Madeleine Fannemel, Olaug Rødningen, Atle Brendehaug, Bjørn Ivar Haukanes, Randi Hovland, Gunnar Helland, Gunnar Houge.
Abstract
MEIS2 is a homeodomain-containing transcription factor of the TALE superfamily that has been proven important for development. We confirm and extend a recent single clinical report stating that deletions in MEIS2 can cause cleft palate [Crowley et al. (2010); Am J Med Genet 152A:1326-1327]. Here we report on five additional patients with 15q14 deletions of sizes 0.6, 0.6, 1.0, 1.9, and 4.8 Mb, respectively, all involving MEIS2. In addition, we present a family with four affected individuals and an intragenic 58 kb direct duplication disrupting MEIS2. In total, 7/9 cases had clefting, from mild (submucous cleft palate) to severe (cleft lip and palate), and 3/9 cases had ventricular septal defects. All cases had delayed motor development and most had learning disability, at worst in the mild intellectual disability range. The cases had overlapping facial features (broad forehead, finely arched eyebrows, mildly shortened philtrum, and tented upper lip) but individually they were not considered to be dysmorphic. Our results show that MEIS2 is a gene needed for palate closure. In syndromic cases of cleft palate, MEIS2 should be considered among the candidate genes, for example, in cases without 22q11.2 deletions.Entities:
Keywords: MEIS2; cleft lip; cleft palate; intellectual disability
Mesh:
Substances:
Year: 2014 PMID: 24678003 DOI: 10.1002/ajmg.a.36498
Source DB: PubMed Journal: Am J Med Genet A ISSN: 1552-4825 Impact factor: 2.802